In development: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Expected publication date

Expected publication date

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 241 to 250 of 386

TitleTypeExpected publication date
Orforglipron for managing overweight and obesity [ID6516]Technology appraisal guidance
Orthopaedic Guidelines on Management of Duchenne Muscular Dystrophy: DMD Care UK standard of care guidelineNICE review
Osimertinib for maintenance treatment of EGFR mutation-positive unresectable locally advanced non-small-cell lung cancer after platinum-based chemoradiotherapy [ID6223]Technology appraisal guidance
Osimertinib for neoadjuvant treatment of EGFR mutation-positive resectable non-small-cell lung cancer [ID6472]Technology appraisal guidanceTBC
OsteoporosisQuality standardTBC
Osteoporosis: risk assessment, treatment, and fragility fracture prevention (update)NICE guideline
Oveporexton for treating type 1 narcolepsy [ID6622]Technology appraisal guidanceTBC
Palforzia for treating peanut allergy in children aged 1 to 3 [ID6144]Technology appraisal guidanceTBC
Palopegteriparatide for treating chronic hypoparathyroidism [ID6380]Technology appraisal guidance
Patritumab deruxtecan for treating EGFR mutation-positive advanced non-small-cell lung cancer after 1 or 2 tyrosine kinase inhibitor treatment [ID6467]Technology appraisal guidanceTBC

Results per page

  1. 10
  2. 25
  3. 50
  4. All